financetom
Business
financetom
/
Business
/
BRIEF-Jinkosolar Repurchased 4,503,178 Adss Under Its Share Repurchase Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Jinkosolar Repurchased 4,503,178 Adss Under Its Share Repurchase Program
Jun 27, 2024 3:26 AM

June 27 (Reuters) - JinkoSolar Holding Co Ltd ( JKS ):

* JINKOSOLAR REPURCHASED 4,503,178 ADSS UNDER ITS SHARE

REPURCHASE

PROGRAM

* JINKOSOLAR HOLDING CO LTD ( JKS ): PROPOSED DEAL FOR AGGREGATE

AMOUNT OF

APPROXIMATELY US$110.7 MILLION IN OPEN MARKET

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alpha Metallurgical Resources' Q1 Earnings, Revenue Decline
Alpha Metallurgical Resources' Q1 Earnings, Revenue Decline
May 6, 2024
07:58 AM EDT, 05/06/2024 (MT Newswires) -- Alpha Metallurgical Resources ( AMR ) reported Q1 net income Monday of $9.59 per diluted share, down from $17.01 a year earlier. Two analysts polled by Capital IQ expected $10.83. Revenue for mining company for the quarter ended March 31 was $864.1 million, compared with $911.2 million a year earlier. Two analysts surveyed...
Top Premarket Decliners
Top Premarket Decliners
May 6, 2024
07:57 AM EDT, 05/06/2024 (MT Newswires) -- Meta Materials ( MMAT ) shares slumped 30% Monday premarket after the company said late Friday its board approved to reduce its workforce by about 80%. Medical Properties Trust ( MPW ) shares fell 15% following a muted session. Mobile-Health Network Solutions ( MNDR ) shares were down 14%, extending Friday's slide. Price:...
Bristol-Myers Squibb Says Applications for Opdivo Accepted by US, European Regulators
Bristol-Myers Squibb Says Applications for Opdivo Accepted by US, European Regulators
May 6, 2024
07:58 AM EDT, 05/06/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Monday that separate applications for Opdivo have been accepted by the US Food and Drug Administration and the European Medicines Agency. The FDA has accepted the biologics license application for the subcutaneous formulation of Opdivo co-formulated with Halozyme's recombinant human hyaluronidase while the EMA has validated the...
Jones Lang LaSalle's Q1 Adjusted Earnings, Revenue Climb
Jones Lang LaSalle's Q1 Adjusted Earnings, Revenue Climb
May 6, 2024
07:59 AM EDT, 05/06/2024 (MT Newswires) -- Jones Lang LaSalle ( JLL ) reported Q1 adjusted earnings Monday of $1.78 per diluted share, up from $0.71 a year earlier. Analysts polled by Capital IQ expected $0.86. Revenue for the quarter ended March 31 was $5.12 billion, up from $4.72 billion a year earlier. Analysts polled by Capital IQ expected $4.82...
Copyright 2023-2026 - www.financetom.com All Rights Reserved